Protease Activated Receptor-4 antagonist
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Protease Activated Receptor-4 antagonist, covering 2018-06-12 to 2018-06-12. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy Study of a Protease Activated Receptor-4 Antagonist Being Tested to Reduce the Chances of Having Additional Strokes or "Mini Strokes" [Phase 2]